Does DILTIAZEM Cause Basal cell carcinoma? 15 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Basal cell carcinoma have been filed in association with DILTIAZEM (Cardizem CD). This represents 0.1% of all adverse event reports for DILTIAZEM.
15
Reports of Basal cell carcinoma with DILTIAZEM
0.1%
of all DILTIAZEM reports
0
Deaths
8
Hospitalizations
How Dangerous Is Basal cell carcinoma From DILTIAZEM?
Of the 15 reports, 8 (53.3%) required hospitalization.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DILTIAZEM. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does DILTIAZEM Cause?
Completed suicide (1,696)
Toxicity to various agents (1,663)
Hypotension (1,550)
Dyspnoea (1,436)
Drug ineffective (1,315)
Fall (1,262)
Pain (1,169)
Dizziness (1,091)
Fatigue (1,054)
Headache (874)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which DILTIAZEM Alternatives Have Lower Basal cell carcinoma Risk?
DILTIAZEM vs DIMENHYDRINATE
DILTIAZEM vs DIMETHICONE
DILTIAZEM vs DIMETHICONE\LOPERAMIDE
DILTIAZEM vs DIMETHINDENE
DILTIAZEM vs DIMETHYL